MSD's headquarters in Spain recognized with the Universal Design Silver 2025 certification... 11/12/2025 Healthcare It acknowledges MSD’s commitment to creating an environment designed to foster a diverse, inclusive, and flexible... Partners - MSD
Building Enduring Capabilities Through a Pioneering NLRP3 Biomarker Program 11/12/2025 Healthcare Access to innovation The development of novel biomarkers represents one of the most challenging frontiers in biotechnology, requiring the... Partners - VIVA IN VITRO
How biotechnology is reshaping pharmaceutical manufacturing: key insights from Klinea’s ex... 11/12/2025 Healthcare Innovative drugs Biotechnology is rapidly transforming the pharmaceutical landscape—yet its industrialisation presents challenges that... Partners - Klinea Biotech & Pharma Engineering
BCN HEALTH publishes a study evaluating the incidence and costs associated with osteogenes... 10/12/2025 Healthcare BCN HEALTH conducted a retrospective study using records of patients diagnosed with osteogenesis imperfecta who were... Partners - BCN Health
Natac obtains the ‘Calculate and Reduce’ seal 10/12/2025 Healthcare Climate change The company has achieved a 14.44% reduction in the average emission intensity for the 2022–2024 period compared to 2021... Partners - Natac Group
Biohope Announces Collaboration to Advance Immunobiogram Diagnostic Solution to Optimize I... 10/12/2025 Healthcare Access to innovation Biohope, a Spanish company specialized in personalized medicine solutions for transplant and autoimmune patients, has... Partners - Biohope
A pivotal year for PVpharm, which, in addition to its pharmacovigilance and clinical safet... 09/12/2025 Healthcare Corporate Among the most notable milestones are the sponsorship of the first edition of the Pharmacovigilance Forum, which... Partners - PVpharm
ORYZON presents data for iadademstat combinations in AML at the American Society of Hemato... 09/12/2025 Healthcare 100% Overall response rate (ORR) in triple combo study with azacitidine and venetoclax in newly diagnosed AML patients Partners - Oryzon Genomics
